BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 30281533)

  • 1. Efficacy of Neulasta or Neupogen on H-ARS and GI-ARS Mortality and Hematopoietic Recovery in Nonhuman Primates After 10-Gy Irradiation With 2.5% Bone Marrow Sparing.
    Farese AM; Bennett AW; Gibbs AM; Hankey KG; Prado K; Jackson W; MacVittie TJ
    Health Phys; 2019 Mar; 116(3):339-353. PubMed ID: 30281533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Radiation Dose and Variation in Neupogen® Initiation Schedule on the Mitigation of Myelosuppression during the Concomitant GI-ARS and H-ARS in a Nonhuman Primate Model of High-dose Exposure with Marrow Sparing.
    MacVittie TJ; Bennett AW; Farese AM; Taylor-Howell C; Smith CP; Gibbs AM; Prado K; Jackson W
    Health Phys; 2015 Nov; 109(5):427-39. PubMed ID: 26425903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Time Course of Radiation-induced Lung Injury in a Nonhuman Primate Model of Partial-body Irradiation With Minimal Bone Marrow Sparing: Clinical and Radiographic Evidence and the Effect of Neupogen Administration.
    MacVittie TJ; Farese AM; Parker GA; Jackson W
    Health Phys; 2019 Mar; 116(3):366-382. PubMed ID: 30624350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation Nephropathy in a Nonhuman Primate Model of Partial-body Irradiation with Minimal Bone Marrow Sparing-Part 1: Acute and Chronic Kidney Injury and the Influence of Neupogen.
    Cohen EP; Hankey KG; Farese AM; Parker GA; Jones JW; Kane MA; Bennett A; MacVittie TJ
    Health Phys; 2019 Mar; 116(3):401-408. PubMed ID: 30608245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival efficacy of the PEGylated G-CSFs Maxy-G34 and neulasta in a mouse model of lethal H-ARS, and residual bone marrow damage in treated survivors.
    Chua HL; Plett PA; Sampson CH; Katz BP; Carnathan GW; MacVittie TJ; Lenden K; Orschell CM
    Health Phys; 2014 Jan; 106(1):21-38. PubMed ID: 24276547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Radiation-induced Lung Injury in the Non-human Primate: A Review and Comparison of Mortality and Co-morbidities Using Models of Partial-body Irradiation with Marginal Bone Marrow Sparing and Whole Thorax Lung Irradiation.
    MacVittie TJ; Farese AM; Parker GA; Bennett AW; Jackson WE
    Health Phys; 2020 Nov; 119(5):559-587. PubMed ID: 33009295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pegfilgrastim Improves Survival of Lethally Irradiated Nonhuman Primates.
    Hankey KG; Farese AM; Blaauw EC; Gibbs AM; Smith CP; Katz BP; Tong Y; Prado KL; MacVittie TJ
    Radiat Res; 2015 Jun; 183(6):643-55. PubMed ID: 26035709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neulasta Regimen for the Hematopoietic Acute Radiation Syndrome: Effects Beyond Neutrophil Recovery.
    Legesse B; Kaur A; Kenchegowda D; Hritzo B; Culp WE; Moroni M
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(4):935-944. PubMed ID: 30496878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ability of filgrastim to mitigate mortality following LD50/60 total-body irradiation is administration time-dependent.
    Farese AM; Brown CR; Smith CP; Gibbs AM; Katz BP; Johnson CS; Prado KL; MacVittie TJ
    Health Phys; 2014 Jan; 106(1):39-47. PubMed ID: 24276548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Plasma Biomarker Utility for the Gastrointestinal Acute Radiation Syndrome in Non-human Primates after Partial Body Irradiation with Minimal Bone Marrow Sparing through Correlation with Tissue and Histological Analyses.
    Kumar P; Wang P; Tudor G; Booth C; Farese AM; MacVittie TJ; Kane MA
    Health Phys; 2020 Nov; 119(5):594-603. PubMed ID: 32947487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioprotective Efficacy of Gamma-Tocotrienol in Nonhuman Primates.
    Singh VK; Kulkarni S; Fatanmi OO; Wise SY; Newman VL; Romaine PL; Hendrickson H; Gulani J; Ghosh SP; Kumar KS; Hauer-Jensen M
    Radiat Res; 2016 Mar; 185(3):285-98. PubMed ID: 26930378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Gottingen minipig is a model of the hematopoietic acute radiation syndrome: G-colony stimulating factor stimulates hematopoiesis and enhances survival from lethal total-body γ-irradiation.
    Moroni M; Ngudiankama BF; Christensen C; Olsen CH; Owens R; Lombardini ED; Holt RK; Whitnall MH
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):986-92. PubMed ID: 23845847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. γ-Tocotrienol as a Promising Countermeasure for Acute Radiation Syndrome: Current Status.
    Singh VK; Hauer-Jensen M
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27153057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelopoietin, an engineered chimeric IL-3 and G-CSF receptor agonist, stimulates multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression.
    MacVittie TJ; Farese AM; Smith WG; Baum CM; Burton E; McKearn JP
    Blood; 2000 Feb; 95(3):837-45. PubMed ID: 10648394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leridistim, a chimeric dual G-CSF and IL-3 receptor agonist, enhances multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression: effect of schedule, dose, and route of administration.
    Farese AM; Casey DB; Smith WG; Vigneulle RM; McKearn JP; MacVittie TJ
    Stem Cells; 2001; 19(6):522-33. PubMed ID: 11713344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Natural History of Acute Radiation-induced H-ARS and Concomitant Multi-organ Injury in the Non-human Primate: The MCART Experience.
    Farese AM; Booth C; Tudor GL; Cui W; Cohen EP; Parker GA; Hankey KG; MacVittie TJ
    Health Phys; 2021 Oct; 121(4):282-303. PubMed ID: 34546213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Filgrastim improves survival in lethally irradiated nonhuman primates.
    Farese AM; Cohen MV; Katz BP; Smith CP; Gibbs A; Cohen DM; MacVittie TJ
    Radiat Res; 2013 Jan; 179(1):89-100. PubMed ID: 23210705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Filgrastim for the treatment of hematopoietic acute radiation syndrome.
    Farese AM; MacVittie TJ
    Drugs Today (Barc); 2015 Sep; 51(9):537-48. PubMed ID: 26488033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Abbreviated Filgrastim Schedule on Survival and Hematopoietic Recovery after Irradiation in Four Mouse Strains with Different Radiosensitivity.
    Satyamitra M; Kumar VP; Biswas S; Cary L; Dickson L; Venkataraman S; Ghosh SP
    Radiat Res; 2017 Jun; 187(6):659-671. PubMed ID: 28362168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prolonged gastrointestinal syndrome in rhesus macaques: the relationship between gastrointestinal, hematopoietic, and delayed multi-organ sequelae following acute, potentially lethal, partial-body irradiation.
    MacVittie TJ; Bennett A; Booth C; Garofalo M; Tudor G; Ward A; Shea-Donohue T; Gelfond D; McFarland E; Jackson W; Lu W; Farese AM
    Health Phys; 2012 Oct; 103(4):427-53. PubMed ID: 22929471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.